Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy (Q42323680)
Jump to navigation
Jump to search
scientific article published on 24 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy |
scientific article published on 24 April 2012 |
Statements
1 reference
Platelet dysfunction associated with ponatinib, a new pan BCR-ABL inhibitor with efficacy for chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitor therapy (English)
1 reference
Pratap Neelakantan
1 reference
David Marin
1 reference
Mike Laffan
1 reference
John Goldman
1 reference
Jane Apperley
1 reference
Dragana Milojkovic
1 reference
Identifiers
1 reference